Factorial Partners’s AngioDynamics ANGO Stock Holding History

Factorial Partners’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,400	Closed	-$159K	–	63
2025 Q4	$159K	Sell	12,400 -11,600	-48%	-$143K	0.11%	62
2025 Q3	$268K	Sell	24,000 -19,000	-44%	-$183K	0.18%	62
2025 Q2	$427K	Sell	43,000 -35,000	-45%	-$343K	0.31%	54
2025 Q1	$732K	Sell	78,000 -35,000	-31%	-$368K	0.45%	57
2024 Q4	$1.04M	Sell	113,000 -3,500	-3%	-$25.7K	0.59%	52
2024 Q3	$906K	Hold	116,500	–	–	0.52%	58
2024 Q2	$705K	Hold	116,500	–	–	0.43%	63
2024 Q1	$684K	Buy	116,500 +28,000	+32%	+$166K	0.39%	68
2023 Q4	$694K	Sell	88,500 -1,000	-1%	-$6.94K	0.44%	63
2023 Q3	$654K	Buy	89,500 +12,000	+15%	+$99.8K	0.48%	62
2023 Q2	$808K	Buy	+77,500	New	+$746K	0.56%	60
2022 Q1	–	Sell	-13,400	Closed	-$370K	–	93
2021 Q4	$370K	Sell	13,400 -8,100	-38%	-$224K	0.24%	83
2021 Q3	$558K	Hold	21,500	–	–	0.38%	76
2021 Q2	$583K	Hold	21,500	–	–	0.39%	76
2021 Q1	$503K	Sell	21,500 -12,500	-37%	-$253K	0.35%	77
2020 Q4	$521K	Sell	34,000 -8,000	-19%	-$102K	0.44%	73
2020 Q3	$507K	Sell	42,000 -17,000	-29%	-$161K	0.52%	67
2020 Q2	$600K	Buy	59,000 +2,500	+4%	+$25.8K	0.66%	51
2020 Q1	$589K	Buy	56,500 +2,500	+5%	+$31.4K	0.79%	43
2019 Q4	$865K	Buy	+54,000	New	+$825K	0.4%	79
2018 Q4	–	Sell	-5,100	Closed	-$111K	–	122
2018 Q3	$111K	Sell	5,100 -4,200	-45%	-$93.3K	0.1%	96
2018 Q2	$207K	Sell	9,300 -40,900	-81%	-$836K	0.18%	90
2018 Q1	$866K	Buy	50,200 +1,000	+2%	+$16.7K	0.79%	50
2017 Q4	$818K	Buy	+49,200	New	+$840K	0.76%	51

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Factorial Partners's ANGO Position: Q1 2026 in Review

Factorial Partners sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 12,400 shares — an estimated $159K sold.

Factorial Partners first reported a position in ANGO in Q4 2017 and held it in 24 quarters. The position peaked at $1.04M in Q4 2024. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

Factorial Partners reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
Factorial Partners sold 12,400 AngioDynamics shares in Q1 2026, an estimated $159K.
Factorial Partners first reported a position in AngioDynamics in Q4 2017 and held it in 24 quarters.
Factorial Partners's AngioDynamics position peaked at $1.04M in Q4 2024.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Factorial Partners's 13F filing for Q1 2026, filed 13 May 2026.